Type 2 diabetes trials in China

In China 189 Also abroad 1200

189 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes
Where
Shenzhen
Age
60 years and over
People
148
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT07007676
Phase 1Not yet taking people in China
A Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus
Where
Beijing
Age
18 years to 65 years
People
10
Run by
Hangzhou Reprogenix Bioscience, Inc
See details and how to joinNCT07794254
Phase 1Taking people
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Where
Kunming
Age
18 years to 50 years
People
36
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803809
Phase 3Taking people
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
Where
Changsha, Changzhou, Dalian, Nanjing, Shanghai
Age
50 years to 75 years
People
420
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07083154
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Binzhou, Changsha, Chengdu, Hangzhou, Jinan, Liaocheng, Liuzhou, Luoyang, Nanjing, Nanyang, Suining Shi, Yibin, Yichang, Zhengzhou
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 2Not yet taking people in China
A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin
Where
Nanjing
Age
18 years to 75 years
People
240
Run by
CSPC Ouyi Pharmaceutical Co., Ltd.
See details and how to joinNCT07796477
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Beijing, Cangzhou, Changchun, Changde, Changzhou, Chengdu, Chongqing, Hefei, Huzhou, Jilin City, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Nanyang, Panjin, Shanghai, Shenzhen, Shijiazhuang, Shiyan, Suzhou, Xining, Zhengzhou, Zhenjiang
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Where
Baotou, Binzhou, Cangzhou, Changsha, Chengdu, Ganzhou, Haikou, Hangzhou, Huangshi, Huzhou, Jinan, Jinzhou, Lanzhou, Lianyungang, Liaocheng, Liuzhou, Loudi, Luoyang, Nanchang, Nanjing, Nanyang, Ningbo, Panjin, Qingdao, Sanmenxia, Shanghai, Suining Shi, Tonghua, Xi'an, Xiangtan, Xuancheng, Yibin, Yichang, Yuncheng, Zhengzhou, Zhenjiang
Age
18 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00
Phase 2Not yet taking people in China
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes
Where
Beijing
Age
18 years to 75 years
People
272
Run by
Chendu DIAO Pharmaceutical Group CO., LTD.
See details and how to joinNCT07755150
Phase 1Taking people
A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
Where
Changsha, Fuzhou, Guangzhou, Hangzhou, Jinan, Langfang, Luoyang, Luzhou, Nanjing, Shanghai, Wuhan, Yichang
Age
18 years to 70 years
People
72
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07747857
No phaseNot yet taking people in China
Clinical Evaluation of Salivary 1,5-Anhydroglucitol in Diabetes
Where
Shanghai
Age
18 years to 80 years
People
180
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT07781683
No phaseNot yet taking people in China
Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD
Where
Putian
Age
30 years to 60 years
People
84
Run by
The 95th Hospital of Putian，Putian, Fujian, China
See details and how to joinNCT07778719
No phaseNot yet taking people in China
CEEEC-II: A 12-Week Physical and Cognitive Enrichment Extension Study in Older Stroke Survivors With Multimorbidity
Where
Kunshan
Age
60 years and over
People
365
Run by
Duke Kunshan University
See details and how to joinNCT07778771
No phaseNot yet taking people in China
Rowing and Cycling Reduce Inflammation in Early-Stage Type 2 Diabetes
Where
Putian
Age
18 years to 60 years
People
120
Run by
The 95th Hospital of Putian，Putian, Fujian, China
See details and how to joinNCT07769840
No phaseNot yet taking people in China
Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
Where
Guangzhou
Age
18 years to 70 years
People
249
Run by
Yanbing Li
See details and how to joinNCT07767552
No phaseNot yet taking people in China
Efficacy and Safety of Hebenrun in Patients With Type 2 Diabetes
Where
Nanchang
Age
18 years to 65 years
People
110
Run by
Jiangxi University of Traditional Chinese Medicine
See details and how to joinNCT07768280
Phase 4Not yet taking people in China
Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
Where
Xi'an
Age
18 years and over
People
462
Run by
Xi'an International Medical Center Hospital
See details and how to joinNCT07747402
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Where
Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang, Pinggu, Pingxiang, Shijiazhuang, Tianjin, Yueyang
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00
No phaseNot yet taking people in China
Blood-based sEV Proteins for Early Detection of 2 Diabetes
Where
Luzhou
Age
40 years to 59 years
People
120 worldwide
Run by
Hong Kong Baptist University
See details and how to joinNCT07728591
No phaseNot yet taking people in China
Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China
Where
Dali
Age
18 years and over
People
720
Run by
The University of Hong Kong
See details and how to joinNCT07718867
No phaseTaking people
Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma
Where
Jinan
Age
18 years and over
People
98
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07722910
No phaseTaking people
Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
Where
Shanghai
Age
18 years to 80 years
People
500
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT07156370
Phase 2Taking people
A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
Where
Beijing, Jinan
Age
18 years to 70 years
People
240
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07599410
Phase 4Taking people
Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Where
Shanghai
Age
40 years to 75 years
People
60
Run by
Fudan University
See details and how to joinNCT07711171
No phaseNot yet taking people in China
Evaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized Trial
Where
Chongqing
Age
18 years to 75 years
People
3,000
Run by
First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07707518